Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Tumor tissue targeted via localized beta radiation refers to the use of radioactive substances that emit beta particles to selectively irradiate and destroy cancer cells within a tumor. This approach is a form of targeted radiotherapy, often called radiopharmaceutical therapy or molecular radiotherapy. It leverages both the physical properties of radioisotopes and biological targeting strategies to maximize anti-tumor efficacy while minimizing off-target toxicity.
Localized beta-emitting radionuclides deliver cytotoxic radiation directly to tumor tissues, causing DNA damage and cell death.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Tumor Tissue (via Localized Beta Radiation).